Zobrazeno 1 - 3
of 3
pro vyhledávání: ''
Autor:
Salvatore Provenzano, Roberta Sanfilippo, Carlo Morosi, Vittoria Colia, Rossella Bertulli, Paola Collini, Paolo G. Casali, Alessandro Gronchi, Silvia Stacchiotti, Elena Fumagalli
Publikováno v:
Sarcoma, Vol 2017 (2017)
Sarcoma
Sarcoma
Background. To report on the activity of high-dose prolonged-infusion ifosfamide (HDIFX) chemotherapy in a retrospective series of patients affected by myxoid liposarcoma treated at Fondazione IRCCS Istituto Nazionale dei Tumori in Milan, Italy. Pati
miR-125b and miR-100 Are Predictive Biomarkers of Response to Induction Chemotherapy in Osteosarcoma
Autor:
Tadashi Kondo, Daisuke Kubota, Yasuhito Arai, Nobuyoshi Kosaka, Takahiro Ochiya, Tomohiro Fujiwara, Akira Kawai, Akihiko Yoshida, Zhiwei Qiao, Fumitaka Takeshita
Publikováno v:
Sarcoma, Vol 2016 (2016)
Sarcoma
Sarcoma
Osteosarcoma is the most common primary malignancy in bone. Patients who respond poorly to induction chemotherapy are at higher risk of adverse prognosis. The molecular basis for such poor prognosis remains unclear. We investigated miRNA expression i
Autor:
Annelies Requilé, Daphne Hompes, Patrick Schöffski, Raf Sciot, Herlinde Dumez, Friedl Sinnaeve, Erik Van Limbergen, Paul Clement, Oliver Bechter, Annelies Verbiest
Publikováno v:
Sarcoma, Vol 2017 (2017)
Sarcoma
Sarcoma
The treatment of Ewing sarcoma (ES) in adult patients requires a multidisciplinary approach. Systemic therapy remains an important component of clinical management of this disease. ES is extremely rare in adult patients. Due to the rarity of the dise